Omid Farokhzad - Net Worth and Insider Trading

Omid Farokhzad Net Worth

The estimated net worth of Omid Farokhzad is at least $3 Million dollars as of 2024-12-27. Omid Farokhzad is the CEO AND CHAIR of Seer Inc and owns about 1,436,285 shares of Seer Inc (SEER) stock worth over $3 Million. Omid Farokhzad is also the Director of Cartesian Therapeutics Inc and owns about 2,778 shares of Cartesian Therapeutics Inc (RNAC) stock worth over $55,227. Details can be seen in Omid Farokhzad's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Omid Farokhzad has not made any transactions after 2024-03-07 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Omid Farokhzad

To

Omid Farokhzad Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Omid Farokhzad owns 5 companies in total, including Cartesian Therapeutics Inc (RNAC) , DNIB Unwind Inc (BINDQ) , and Seer Inc (SEER) among others .

Click here to see the complete history of Omid Farokhzad’s form 4 insider trades.

Insider Ownership Summary of Omid Farokhzad

Ticker Comapny Transaction Date Type of Owner
RNAC Cartesian Therapeutics Inc 2019-01-25 director & 10 percent owner
BINDQ DNIB Unwind Inc 2013-09-19 director
SEER Seer Inc 2024-03-07 director & 10 percent owner & CEO and Chair of the Board
LIMIT LIMIT 2021-05-25 director
LIMIT LIMIT 2021-05-25 director

Omid Farokhzad Latest Holdings Summary

Omid Farokhzad currently owns a total of 2 stocks. Among these stocks, Omid Farokhzad owns 1,436,285 shares of Seer Inc (SEER) as of March 7, 2024, with a value of $3 Million and a weighting of 98.27%. Omid Farokhzad also owns 2,778 shares of Cartesian Therapeutics Inc (RNAC) as of January 25, 2019, with a value of $55,227 and a weighting of 1.73%.

Latest Holdings of Omid Farokhzad

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
SEER Seer Inc 2024-03-07 1,436,285 2.19 3,145,464
RNAC Cartesian Therapeutics Inc 2019-01-25 2,778 19.88 55,227

Holding Weightings of Omid Farokhzad


Omid Farokhzad Form 4 Trading Tracker

According to the SEC Form 4 filings, Omid Farokhzad has made a total of 9 transactions in Seer Inc (SEER) over the past 5 years, including 1 buys and 8 sells. The most-recent trade in Seer Inc is the sale of 52,857 shares on March 7, 2024, which brought Omid Farokhzad around $107,300.

According to the SEC Form 4 filings, Omid Farokhzad has made a total of 0 transactions in Cartesian Therapeutics Inc (RNAC) over the past 5 years. The most-recent trade in Cartesian Therapeutics Inc is the acquisition of 2,778 shares on January 25, 2019, which cost Omid Farokhzad around $125,000.

Insider Trading History of Omid Farokhzad

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Omid Farokhzad Trading Performance

GuruFocus tracks the stock performance after each of Omid Farokhzad's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Omid Farokhzad is -1.36%. GuruFocus also compares Omid Farokhzad's trading performance to market benchmark return within the same time period. The performance of stocks bought by Omid Farokhzad within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Omid Farokhzad's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Omid Farokhzad

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
1 out of 2 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 14.99 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 13.83 LIMIT LIMIT LIMIT LIMIT LIMIT

Omid Farokhzad Ownership Network

Ownership Network List of Omid Farokhzad

No Data

Ownership Network Relation of Omid Farokhzad

Insider Network Chart

Omid Farokhzad Owned Company Details

What does Cartesian Therapeutics Inc do?

Who are the key executives at Cartesian Therapeutics Inc?

Omid Farokhzad is the director & 10 percent owner of Cartesian Therapeutics Inc. Other key executives at Cartesian Therapeutics Inc include Chief Medical Officer Peter G Traber , director & President & CEO Carsten Brunn , and Chief Scientific Officer Takashi Kei Kishimoto .

Cartesian Therapeutics Inc (RNAC) Insider Trades Summary

Over the past 18 months, Omid Farokhzad made no insider transaction in Cartesian Therapeutics Inc (RNAC). Other recent insider transactions involving Cartesian Therapeutics Inc (RNAC) include a net purchase of 1,921,182 shares made by Timothy A Springer , a net sale of 52,115 shares made by , and a net purchase of 7,500 shares made by Timothy C Barabe .

In summary, during the past 3 months, insiders sold 241,836 shares of Cartesian Therapeutics Inc (RNAC) in total and bought 689,850 shares, with a net purchase of 448,014 shares. During the past 18 months, 241,957 shares of Cartesian Therapeutics Inc (RNAC) were sold and 746,143 shares were bought by its insiders, resulting in a net purchase of 504,186 shares.

Cartesian Therapeutics Inc (RNAC)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Cartesian Therapeutics Inc Insider Transactions

No Available Data

Omid Farokhzad Mailing Address

Above is the net worth, insider trading, and ownership report for Omid Farokhzad. You might contact Omid Farokhzad via mailing address: C/o Seer, Inc., 3800 Bridge Parkway, Suite 102, Redwood City Ca 94065.

Discussions on Omid Farokhzad

No discussions yet.